Drug Shortage Report for AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR
| Report ID | 129766 |
| Drug Identification Number | 02478404 |
| Brand name | AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR |
| Common or Proper name | EFAVIRENZ-EMTRICITABINE-TENOFOVIR |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | EFAVIRENZ EMTRICITABINE TENOFOVIR DISOPROXIL FUMARATE |
| Strength(s) | 600MG 200MG 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30s |
| ATC code | J05AR |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2020-12-04 |
| Actual start date | |
| Estimated end date | 2021-04-01 |
| Actual end date | 2020-03-26 |
| Shortage status | Avoided shortage |
| Updated date | 2021-02-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2021-02-03 | French | Compare |
| v11 | 2021-02-03 | English | Compare |
| v10 | 2021-01-19 | French | Compare |
| v9 | 2021-01-19 | English | Compare |
| v8 | 2021-01-07 | French | Compare |
| v7 | 2021-01-07 | English | Compare |
| v6 | 2021-01-07 | French | Compare |
| v5 | 2021-01-07 | English | Compare |
| v4 | 2020-12-24 | French | Compare |
| v3 | 2020-12-24 | English | Compare |
| v2 | 2020-12-07 | French | Compare |
| v1 | 2020-12-07 | English | Compare |
Showing 1 to 12 of 12